Towards a commercial process for the manufacture of genetically modified T cells for therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Towards a commercial process for the manufacture of genetically modified T cells for therapy
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 22, Issue 2, Pages 72-78
Publisher
Springer Nature
Online
2015-01-23
DOI
10.1038/cgt.2014.78
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adoptive Immunotherapy for Cancer or Viruses
- (2014) Marcela V. Maus et al. Annual Review of Immunology
- Antibody-modified T cells: CARs take the front seat for hematologic malignancies
- (2014) M. V. Maus et al. BLOOD
- Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
- (2014) Y. Xu et al. BLOOD
- Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
- (2014) Raquel Gomez-Eerland et al. Human Gene Therapy Methods
- Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
- (2013) A. M. Leen et al. BLOOD
- Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
- (2013) H. Torikai et al. BLOOD
- Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients
- (2013) Anna Casati et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture
- (2013) Michael Apel et al. CHEMIE INGENIEUR TECHNIK
- A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI)
- (2013) Lisa K. McNeil et al. CYTOMETRY PART A
- Simplified process for the production of anti–CD19-CAR–engineered T cells
- (2013) Barbara Tumaini et al. CYTOTHERAPY
- Engineered T cells for cancer treatment
- (2013) Usanarat Anurathapan et al. CYTOTHERAPY
- A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells
- (2013) M. M. van Loenen et al. HAEMATOLOGICA
- Critical assessment of automated flow cytometry data analysis techniques
- (2013) Nima Aghaeepour et al. NATURE METHODS
- A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
- (2012) H. Torikai et al. BLOOD
- Will T-cell therapy for cancer ever be a standard of care?
- (2012) M K Brenner CANCER GENE THERAPY
- Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
- (2012) M. J. Goldstein et al. CANCER RESEARCH
- The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
- (2012) D. W. Lee et al. CLINICAL CANCER RESEARCH
- Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer
- (2012) Thomas Decker et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Sorting Through Subsets
- (2012) Christopher A. Klebanoff et al. JOURNAL OF IMMUNOTHERAPY
- Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment
- (2012) Jianjian Jin et al. JOURNAL OF IMMUNOTHERAPY
- Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor
- (2012) Robert PT Somerville et al. Journal of Translational Medicine
- Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
- (2011) S. Terakura et al. BLOOD
- Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection
- (2011) A. Biffi et al. BLOOD
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Lentiviral Vectors: Their Molecular Design, Safety, and Use in Laboratory and Preclinical Research
- (2011) Boro Dropulić HUMAN GENE THERAPY
- Biomarkers in T cell therapy clinical trials
- (2011) Michael Kalos Journal of Translational Medicine
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Peak serum: implications of serum supply for cell therapy manufacturing
- (2011) David A Brindley et al. Regenerative Medicine
- Harmonization of Immune Biomarker Assays for Clinical Studies
- (2011) S. H. van der Burg et al. Science Translational Medicine
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Treating cancer with genetically engineered T cells
- (2011) Tristen S. Park et al. TRENDS IN BIOTECHNOLOGY
- Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
- (2010) C. S. Hinrichs et al. BLOOD
- Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells
- (2009) Gary P Wang et al. MOLECULAR THERAPY
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now